An official website of the United States government
Event Details
Description of Event
Malaria Drug Resistance
- Global pandemic of fake medicines poses urgent risk, scientists say
Fogarty/NIH news, April 20, 2015- Related publications: The Global Pandemic of Falsified Medicines: Laboratory and Field Innovations and Policy Perspectives
June 2015 supplement to the American Journal of Tropical Medicine and Hygiene, published online April 20, 2015 - Stemming the tide of fake medicines
New York Times editorial, May 18, 2015 - Why researchers say fake and low-quality drugs are a 'global pandemic'
Washington Post, April 20, 2015 - Substandard drugs, not fakes, undermine fight against malaria
Reuters Health, April 20, 2015 - Fake medicines do real damage: Thousands die, superbugs get stronger according to Fogarty Senior Scientist Emeritus Dr Joel Breman
NPR Goats and Soda blog, April 24, 2015
- Related publications: The Global Pandemic of Falsified Medicines: Laboratory and Field Innovations and Policy Perspectives
- Study shows parasite mutation behind drug-resistant malaria in Cambodia
Jan / Feb 2014 Global Health Matters\ - FDA acts against compromised antimalarial drugs
May / Jun 2013 Global Health Matters- NIH partners with FDA: FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool
FDA News, April 24, 2013
- NIH partners with FDA: FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool
- Resistance to malaria drugs is a growing concern
Sep / Oct 2012 Global Health Matters- Related publication: Counterfeit antimalarial drugs
The Lancet Infectious Diseases, November 2012
- Related publication: Counterfeit antimalarial drugs
- Meeting report on Fogarty and NIAID conference on artemisinin-resistant malaria: Artemisinin-resistant malaria: Research challenges, opportunities and public health implications
American Journal of Tropical Medicine and Hygiene, August 2012 - Fogarty study shows poor quality and fake malaria drugs pose threat
May / Jun 2012 Global Health Matters - NIH study shows poor quality malaria drugs pose threat:
Drug resistance a growing concern in Southeast Asia and sub-Saharan Africa
NIH News, May 21, 2012
Related Research Topics
Related Fogarty Opportunities
- Ecology and Evolution of Infectious Diseases Initiative (EEID)
- Global Infectious Disease Research Training Program (GID)
Poor quality malaria drugs pose threat
Poor quality antimalarial drugs lead to drug resistance and inadequate treatment that pose an urgent threat to vulnerable populations, according to a Fogarty study.
Resistance to malaria drugs is a growing concern
Fogarty and NIAID convened drug-resistant malaria experts to examine the problem, identify possible approaches, spark collaborations and spur the field to take action.
Mutation behind drug-resistant malaria
An international collaboration that includes NIAID uncovered a mutation in the malaria parasite in Cambodia that enables it to survive artemisinin, the most potent antimalarial drug available.